The effect of RheothRx injection on the hemorheological parameters in patients with acute myocardial infarction

K. Toth, L. Bogar, I. Juricskay, M. Keltai, S. Yusuf, L. J. Haywood, H. J. Meiselman

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

This study evaluated the hemorheological effects of a nonionic block copolymer surfactant, RheothRx Injection, on the hemorheological parameters in patients with acute myocardial infarction (AMI). For the in vitro study blood from 24 patients admitted with chest pains (mean age: 49 ± 11 yrs) was sampled after admission and in AMI cases (15 patients, mean age: 53 ± 13 yrs) a second sample was collected 48 hours latch Different concentrations of RheothRx were added (0.25, 0.5, 1, 2 and 5 mg/ml) and the blood was tested for RBC aggregation via our computerized Myrenne Aggregometer (at Hct = 40%). Besides other routine laboratory parameters, fibrinogen levels were measured. In a substudy for CORE Trial, the hemorheological effects of RheothRx infusion was studied. Seven patients (mean age: 63 ± 13 yrs) admitted with AMI and randomized for CORE Trial were studied. The samples were collected after admission, at 12, 24, 48 hours, and at day 8 and 35. In vitro we found a significant (p < 0.05 or better) concentration-related decrease of RB(2 aggregation from 0.5 mg/ml drug concentration in the admission (both groups) and in the 48 hour (AMI) samples, in AMI patients with a mean decrease of 7 and 5% at 0.5 mg/ml, 13 and 8% at 1 mg/ml, 22 and 19% at 2 mg/ml and 39 and 33% at 5 mg/ml plasma concentration of the drug. In the CORE Trial patients hemorheological parameters (plasma and whole blood viscosity, RBC aggregation and fibrinogen level) decreased during and after the administration of RheothRx, but after 2-8 days their values returned to the baseline level. These findings indicate that this agent can significantly reduce RBC aggregation and other hemorheological parameters, and thus suggest its potential usefulness in clinical states associated with increased RBC aggregation.

Original languageEnglish
Pages (from-to)117-125
Number of pages9
JournalClinical hemorheology and microcirculation
Volume17
Issue number2
Publication statusPublished - Nov 13 1997

ASJC Scopus subject areas

  • Physiology
  • Hematology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Fingerprint Dive into the research topics of 'The effect of RheothRx injection on the hemorheological parameters in patients with acute myocardial infarction'. Together they form a unique fingerprint.

  • Cite this